Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential
By K. Shay, R. Moreau, Eric J. Smith, Anthony R. W. Smith, T. Hagen. Biochimica et Biophysica Acta, 2009
958 citations recorded by the source corpus.
Alpha-lipoic acid (LA) has become a common ingredient in multivitamin formulas, anti-aging supplements, and even pet food. It is well-defined as a therapy for preventing diabetic polyneuropathies, and scavenges free radicals, chelates metals, and restores intracellular glutathione levels which otherwise decline with age. How do the biochemical properties of LA relate to its biological effects? Herein, we review the molecular mechanisms of LA discovered using cell and animal models, and the effects of LA on human subjects. Though LA has long been touted as an antioxidant, it has also been shown to improve glucose and ascorbate handling, increase eNOS activity, activate Phase II detoxification via the transcription factor Nrf2, and lower expression of MMP-9 and VCAM-1 through repression of NF-kappa-B. LA and its reduced form, dihydrolipoic acid, may use their chemical properties as a redox couple to alter protein conformations by forming mixed disulfides. Beneficial effects are achieved with low micromolar levels of LA, suggesting that some of its therapeutic potential extends beyond the strict definition of an antioxidant. Current trials are investigating whether these beneficial properties of LA make it an appropriate treatment not just for diabetes, but also for the prevention of vascular disease, hypertension, and inflammation.
Subfields: Biochemistry, Molecular Biology, Nutrition and Dietetics
View Paper: https://www.semanticscholar.org/paper/79877f00792338757d5de97f055175bee7a2718f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- L. Zuo
- Zewen Liu
- Eswar Kandaswamy
- Chia-Chen Chuang
- Zhangpin Ren
- Jun Zhang
- Tingyang Zhou
Citations in the corpus
- Role of ROS and Nutritional Antioxidants in Human Diseases (2018, background): “In the progression stage of cancer development, ROS contribute to the upregulation of matrix metalloproteinases, inhibiting the action of anti-proteases and angiogenesis, eventually leading to metastasis (Maulik, 2002; Mori et al., 2004; Shinohara et al., 2010).”